【レポートの概要(一部)】
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits to Stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porters five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Threat of new entrants
3.3.3. Threat of substitutes
3.3.4. Competitive rivalry
3.3.5. Bargaining power among buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in the Incidences of Acute Lymphoblastic Leukemia
3.4.1.2. Rise in Number of New Product Approvals
3.4.2. Restraints
3.4.2.1. Patent Expiry of Blockbuster Drugs
3.4.2.2. Side effects of the treatment
3.4.3. Opportunity
3.4.3.1. Increase in number of Clinical Trials
CHAPTER 4: ACUTE LYMPHOCYTIC LEUKEMIA MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Pediatric
4.2.1. Market size and forecast
4.3. Adult
4.3.1. Market size and forecast
CHAPTER 5: ACUTE LYMPHOCYTIC LEUKEMIA THERAPEUTICS MARKET, BY DRUG
5.1. Overvie
5.1.1. Market size and forecast
5.2. Hyper-CVAD regimen
5.2.1. Market size and forecast
5.3. Linker regimen
5.3.1. Market size and forecast
5.4. Nucleoside metabolic inhibitors (Clolar and Nelarabine)
5.4.1. Market size and forecast
5.5. Targeted drugs & immunotherapy
5.5.1. Market size and forecast
5.6. CALGB 8811 regimen
5.6.1. Market size and forecast
5.7. Oncaspar
5.7.1. Market size and forecast
CHAPTER 6: ACUTE LYMPHOCYTIC/LYMPHOBLASTIC LEUKEMIA THERAPEUTICS MARKET, BY REGION
6.1. Overview
6.1.1. Market size and forecast
6.2. North America
6.2.1. Key market trends and opportunities
6.3. Europe
6.3.1. Key market trends and opportunities
6.4. Asia-Pacific
6.4.1. Key market trends and opportunities
6.5. LAMEA
6.5.1. Key market trends and opportunities
CHAPTER 7: COMPANY PROFILES
7.1. AMGEN, INC
7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product portfolio
7.1.5. Business performance
7.1.6. Key strategic moves and developments
7.2. BRISTOL-MYERS SQUIBB COMPANY
7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments
7.3. ERYTECH PHARMA
7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Product portfolio
7.3.4. Key strategic moves and developments
7.4. LEADIANT BIOSCIENCES, INC. (SIGMA-TAU PHARMACEUTICALS INC.)
7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Product portfolio
7.5. NOVARTIS AG
7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product portfolio
7.5.5. Business performance
7.5.6. Key strategic moves and developments
7.6. PFIZER, INC
7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segments
7.6.4. Product portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments
7.7. RARE DISEASE THERAPEUTICS, INC.
7.7.1. Company overview
7.7.2. Company snapshot
7.7.3. Operating business segments
7.7.4. Product portfolio
7.8. SANOFI
7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Product portfolio
7.8.4. Business performance
7.9. SPECTRUM PHARMACEUTICALS, INC
7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product portfolio
7.9.5. Business performance
7.9.6. Key strategic moves and developments
7.10. TAKEDA PHARMACEUTICAL COMPANY LIMITED
7.10.1. Company overview
7.10.2. Operating business segments
7.10.3. Product portfolio
7.10.4. Key strategic moves and developments
【レポート販売概要】
■ タイトル:急性リンパ球/リンパ芽球性白血病 (ALL)治療法の世界市場:薬別(ハイパーCVADレジメン、リンカーレジメン、ヌクレオシド代謝阻害剤、標的薬物および免疫療法、CALGB 8811レジメン、およびオンカスパー)、種類別(小児および成人)■ 英文:Acute Lymphocytic/Lymphoblastic Leukemia (ALL) Therapeutics Market by Drug (Hyper-CVAD Regimen, Linker Regimen, Nucleoside Metabolic Inhibitors, Targeted Drugs & Immunotherapy, CALGB 8811 Regimen, and Oncaspar), and Type (Pediatric and Adult): Global Opportunity Analysis and Industry Forecast, 2019–2026
■ 発行日:2019年6月30日
■ 調査会社:Allied Market Research
■ 商品コード:AMR9AG045
■ 調査対象地域:グローバル
- 自動車アクスル(車軸)及びプロペラシャフトの世界市場:ライブ車軸、固定車軸、タンデム車軸、フロント/リア/車軸間プロペラシャフトThe demand for automotive axles and propeller shafts is governed by global vehicle production. Axles are designed to bear the weight of the vehicle, and are required to be lightweight for fuel-efficiency and structurally stiff to handle the vehicle’s powertrain requirements given the increased torque. Tier I suppliers are developing new technologies, focusing on reduction of fuel consumption. Supp …
- 急性咽頭炎(Acute Pharyngitis):世界の治験レビュー2014年下半期版Acute Pharyngitis Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Acute Pharyngitis Global Clinical Trials Review, H2, 2014" provides data on the Acute Pharyngitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Acute Pharyngitis. It includes an overview of the trial numbers and their recruitment s …
- 乗用車用GPF(ガソリン・パティキュレート・フィルタ)の世界市場2016-2020About GPFs GPFs are used for controlling the emission levels of particulate matter number of direct fuel injected gasoline cars. They are fitted with the exhaust system of the vehicle. The filter’s substrate wall traps and collects the particulate matter from the engine exhaust gases before releasing, reducing the particulate emission levels. Technavio’s analysts forecast the global gasoline parti …
- ドイツの注射器・注射針市場見通し(~2021)Germany Syringes and Needles Market Outlook to 2021 Summary GlobalData’s new report, "Germany Syringes and Needles Market Outlook to 2021", provides key market data on the Germany Syringes and Needles market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - General Syringes and Specialized Syringes. The report …
- エポキシコーティングの世界市場分析:製品別(溶剤系、水系、粉末)、用途別(建設、産業、輸送)、セグメント予測The global epoxy coating market is expected to reach USD 41.71 billion by 2024, according to a new report by Grand View Research, Inc. Increase in spending on residential and commercial construction in emerging regions such as Asia Pacific and Middle East is expected to drive global Epoxy Coating Market growth over the next eight years. Rapid industrialization in Asia Pacific has resulted in an in …
- 医療ホログラフィの世界市場分析:製品別(ホログラフィックディスプレイ、レーザー、接触式、ピストン、半透明、顕微鏡、印刷、ソフトウェア)、用途別、エンドユーザー別、セグメント予測、2014-2025The medical holography market is expected to reach USD 4.04 billion by 2025, according to a new study by Grand View Research, Inc. The medical holography market is predominantly driven by the increasing penetration of holographic displays in diagnostic imaging for educational and training purposes due to the generation of high quality 3D images, which provide a better insight into disease progress …
- クリーンエネルギー技術の世界市場2019-2023About this market The rising demand for clean energy sources will drive the clean energy technologies market growth during the forecast period. Surging demand for electricity and the extensive use of fossil fuels such as coal and natural gas for fulfilling the need has increased carbon emissions. The demand for clean energy sources is likely to surge considerably at global levels for reducing carb …
- 世界の血液分析器市場動向(2012-2016)TechNavio's analysts forecast the Global Hematology Analyzers market to grow at a CAGR of 3.59 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing aging population. The Global Hematology Analyzers market has also been witnessing the consolidation of the Industrial sector. However, the high cost of hematology analyzers could pose a challeng …
- 自動車V2X(Vehicle to Everything)通信の世界市場:V2V、V2I、V2P、V2H、IN-V、ITS、Car-to-X、コネクテッドカーThe latest report from business intelligence provider visiongain offers comprehensive analysis of the global automotive vehicle-to-everything (V2X) market. Visiongain assesses that in vehicle (IN-V) communications will generate revenues of $29.4 billion in 2015. Now: The latest announcement of AT&T financial results at the end of July stated that during 2015 among the 2.1 million new wireless conn …
- Focal Segmental Glomerulosclerosis (FSGS):グローバル臨床試験レビューH2, 2013Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2013" provides data on the Focal Segmental Glomerulosclerosis (FSGS) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Focal Segmental …
- リスク分析ソフトウェアの世界市場予測(~2021)MarketsandMarkets forecasts the risk analytics market to grow from USD 16.55 Billion in 2016 to USD 30.18 Billion by 2021, at a Compound Annual Growth Rate (CAGR) of 12.8%. In the last 5 years, risk analytics solutions have significantly evolved due to the organizational need to accelerate and streamline risk processes in order to reduce cost from credit losses and manage operational risk. The mar …
- 神経ガス自動注入装置の世界市場Nerve gas auto injector is important self-aid equipment which helps the soldiers to protect themselves from the effects of the chemical agents during the wars. North America accounted for the major market share for the nerve gas auto injector market in 2015 followed by Europe. Within North America, U.S. accounted for the major market share.Pacific and Middle East have relatively smaller market sha …
- ファサードの世界市場:最終用途別(商業用、住宅用、工業用)、製品別(換気、非換気)、地域別、セグメント予測The global facade market size is anticipated to reach USD 342.94 billion by 2025, according to a new report by Grand View Research, Inc., exhibiting a CAGR of 7.6% during the forecast period.The market is estimated to register healthy growth over the forecast period owing to development of advanced materials with capabilities that offer safety as well as visually appealing texture. This exterior b …
- 酢酸エチル(ETAC)の世界市場予測Ethyl acetate 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about ethyl acetate market in the all-in-one report issued in a logical and easily accessible format. In addition to the analytical pa …
- 体外受精(IVF)のイギリス市場:サイクルタイプ別、エンドユーザー別The UK IVF market was valued at $514 million in 2018 and is estimated to reach $928 million by 2026, registering a CAGR of 7.6% during the analysis period. In-vitro-Fertilization (IVF) is a common artificial infertility treatment performed in the laboratory. The treatment involves removing an ova (egg or eggs) or ovum from the ovaries and allowing sperm to fertilize them in a laboratory dish. It i …